Zhiliang Chen

This inventor holds 6 USPTO granted patents and 6 EPO patents. Top assignees: Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., Medshine Discovery Inc.. Active years: 2021-2023.

USPTO Granted Patents = 6

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 7.8

ph-index = 1

Location History:

Fujian, CN (2021 - 2022)
Zhangzhou, CN (2023)

Company Filing History:

6 out of 15

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

patents

1 out of 71

Medshine Discovery Inc.

patents

where one patent can have more than one assignee

Years Active: 2021-2023

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11708357 - Crystal form of pyrrolidinyl urea derivative and application thereof (2023-07-25),

2. 11673899 - Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof (2023-06-13),

3. 11603366 - Crystalline form and B crystalline form of pyrazine-2(1H)-ketone compound and preparation method thereof (2023-03-14),

4. 11597722 - Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor (2023-03-07),

5. 11266704 - Total flavonoid extract fromKitam., preparation method thereof, and use of same in treating non-alcoholic fatty liver disease (2022-03-08),

6. 11185566 - Total flavonoid extract from Gynura formosana Kitam., preparation method thereof, and use of same in preparing drug or health product related to alcoholic fatty liver disease (2021-11-30),

Title: Innovations and Contributions of Inventor Zhiliang Chen

Introduction

Zhiliang Chen is a notable inventor based in Zhangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of six patents to his name, Chen's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents is the "Crystal form of pyrrolidinyl urea derivative and application thereof." This invention discloses a crystal form of a TrkA inhibitor, along with a preparation method and its application in developing drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases. Another significant patent is the "Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof." This patent details a crystal form of a thieno[2,3-c]pyridazine-4(1H)-one compound, its preparation method, and its use as an inhibitor of ACC1 and ACC2 in drug development.

Career Highlights

Zhiliang Chen has worked with prominent companies in the pharmaceutical industry, including Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. and Medshine Discovery Inc. His experience in these organizations has allowed him to contribute to innovative drug development processes.

Collaborations

Chen has collaborated with notable colleagues such as Juan Yu and Fei Hong, enhancing his research and development efforts in the pharmaceutical sector.

Conclusion

Zhiliang Chen's innovative work and patents reflect his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of various diseases.